Joel Greenblatt Enanta Pharmaceuticals Inc Transaction History

Gotham Asset Management, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 13, 2020	SELL	$46.37 - $57.58 $648,716 - $805,544	-13,990 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$40.22 - $62.0 $622,967 - $960,318	-15,489 Reduced 52.54%	13,990 $720,000
Q4 2019 Feb 14, 2020	SELL	$57.95 - $66.61 $642,723 - $738,771	-11,091 Reduced 27.34%	29,479 $1.82 Million
Q3 2019 Nov 14, 2019	BUY	$60.08 - $88.17 $494,158 - $725,198	8,225 Added 25.43%	40,570 $2.44 Million
Q2 2019 Aug 14, 2019	BUY	$81.3 - $97.35 $1.11 Million - $1.33 Million	13,693 Added 73.41%	32,345 $2.73 Million
Q1 2019 May 15, 2019	SELL	$69.08 - $105.66 $264,576 - $404,677	-3,830 Reduced 17.04%	18,652 $1.78 Million
Q4 2018 Feb 14, 2019	SELL	$65.41 - $84.65 $507,058 - $656,206	-7,752 Reduced 25.64%	22,482 $1.59 Million
Q3 2018 Nov 14, 2018	BUY	$85.46 - $126.37 $1.29 Million - $1.9 Million	15,062 Added 99.27%	30,234 $2.58 Million
Q2 2018 Aug 14, 2018	SELL	$81.85 - $120.51 $6,302 - $9,279	-77 Reduced 0.5%	15,172 $1.76 Million
Q1 2018 May 15, 2018	BUY	$57.91 - $92.15 $230,076 - $366,111	3,973 Added 35.23%	15,249 $1.23 Million
Q4 2017 Feb 14, 2018	SELL	$45.65 - $59.37 $38,163 - $49,633	-836 Reduced 6.9%	11,276 $662,000
Q3 2017 Nov 14, 2017	BUY	$37.91 - $46.8 $459,165 - $566,841	12,112	12,112 $567,000

110

21.1M

4.8K

4.6K

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $188M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

Get notified when there are updates to the investment portfolio of Gotham Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Gotham Asset Management, LLC and Joel Greenblatt with notifications on news.